Analysts think AMGN stock price could increase by 11%
Jun 04, 2025, 11:25 AM
-5.95%
What does AMGN do
Amgen, headquartered in Thousand Oaks, California, is a biotechnology company employing 26,700 staff, focusing on developing human therapeutics for high unmet medical needs. Its product portfolio includes Aranesp, ENBREL, and Prolia, among others.
30 analysts think AMGN stock price will increase by 10.94%. The current median analyst target is $321.30 compared to a current stock price of $289.61. The lowest analysts target is $186.85 and the highest analyst target is $420.00.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.